Lurasidone has been shown to modulate BDNF expression at both mRNA and protein levels in the prefrontal cortex and hippocampus, suggesting a neuroprotective role that could ameliorate cognitive deficits in schizophrenia [126]. This evidence concerns the gene BDNF and schizophrenia.